Andrea Matucci

Years Active: 2023-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Alessandra Vultaggio, Matteo Accinno, Emanuele Vivarelli, Valentina Mecheri, Giandomenico Maggiore, Lorenzo Cosmi, Paola Parronchi, Olivero Rossi, Enrico Maggi, Oreste Gallo, Andrea Matucci
Blood CD62L low inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab. Allergy (2023)
Marco Caminati, Roland Buhl, Jonathan Corren, Nicola A Hanania, Harold Kim, Stephanie Korn, Marek Lommatzsch, Neil Martin, Andrea Matucci, Shuaib M Nasser, Ian Douglas Pavord, Christian Domingo
Tezepelumab in patients with allergic and eosinophilic asthma. Allergy 79 (5) (2023)
Marco Caminati, Roland Buhl, Jonathan Corren, Nicola A Hanania, Harold Kim, Stephanie Korn, Marek Lommatzsch, Neil Martin, Andrea Matucci, Shuaib M Nasser, Ian Douglas Pavord, Christian Domingo
Tezepelumab in patients with allergic and eosinophilic asthma. Allergy (2023)
Marco Caminati, Roland Buhl, Jonathan Corren, Nicola A Hanania, Harold Kim, Stephanie Korn, Marek Lommatzsch, Neil Martin, Andrea Matucci, Shuaib M Nasser, Ian Douglas Pavord, Christian Domingo
Tezepelumab in patients with allergic and eosinophilic asthma. Allergy 79 (5) (2023)
Marco Caminati, Roland Buhl, Jonathan Corren, Nicola A Hanania, Harold Kim, Stephanie Korn, Marek Lommatzsch, Neil Martin, Andrea Matucci, Shuaib M Nasser, Ian Douglas Pavord, Christian Domingo
Tezepelumab in patients with allergic and eosinophilic asthma. Allergy 79 (5) (2023)

Andrea Matucci.css-eqlu8i{font-size:small;padding-left:4px;}